149 related articles for article (PubMed ID: 9551491)
1. The neuroanatomy and neurochemistry of schizophrenia.
Weickert CS; Kleinman JE
Psychiatr Clin North Am; 1998 Mar; 21(1):57-75. PubMed ID: 9551491
[TBL] [Abstract][Full Text] [Related]
2. The neuropathology of schizophrenia.
Bachus SE; Kleinman JE
J Clin Psychiatry; 1996; 57 Suppl 11():72-83. PubMed ID: 8941174
[TBL] [Abstract][Full Text] [Related]
3. Molecular brain imaging and the neurobiology and genetics of schizophrenia.
Heinz A; Romero B; Gallinat J; Juckel G; Weinberger DR
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S152-7. PubMed ID: 14677072
[TBL] [Abstract][Full Text] [Related]
4. Pathway-Specific Dopamine Abnormalities in Schizophrenia.
Weinstein JJ; Chohan MO; Slifstein M; Kegeles LS; Moore H; Abi-Dargham A
Biol Psychiatry; 2017 Jan; 81(1):31-42. PubMed ID: 27206569
[TBL] [Abstract][Full Text] [Related]
5. Limbic cortical injury sustained during adulthood leads to schizophrenia-like syndrome.
Jaskiw GE; Kenny JF
Schizophr Res; 2002 Dec; 58(2-3):205-12. PubMed ID: 12409160
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.
Ghose S; Crook JM; Bartus CL; Sherman TG; Herman MM; Hyde TM; Kleinman JE; Akil M
Int J Neurosci; 2008 Nov; 118(11):1609-27. PubMed ID: 18853337
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical imaging in schizophrenia.
Urban N; Abi-Dargham A
Curr Top Behav Neurosci; 2010; 4():215-42. PubMed ID: 21312402
[TBL] [Abstract][Full Text] [Related]
8. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.
Ohrmann P; Kugel H; Bauer J; Siegmund A; Kölkebeck K; Suslow T; Wiedl KH; Rothermundt M; Arolt V; Pedersen A
Schizophr Res; 2008 Dec; 106(2-3):156-63. PubMed ID: 18799290
[TBL] [Abstract][Full Text] [Related]
9. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain.
Benes FM
Arch Gen Psychiatry; 1995 Dec; 52(12):1015-8; discussion 1019-24. PubMed ID: 7492253
[No Abstract] [Full Text] [Related]
10. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.
Gupta DS; McCullumsmith RE; Beneyto M; Haroutunian V; Davis KL; Meador-Woodruff JH
Synapse; 2005 Sep; 57(3):123-31. PubMed ID: 15945063
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
Hyde TM; Crook JM
J Chem Neuroanat; 2001 Jul; 22(1-2):53-63. PubMed ID: 11470554
[TBL] [Abstract][Full Text] [Related]
12. Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease.
Selemon LD
Schizophr Bull; 2001; 27(3):349-77. PubMed ID: 11596841
[TBL] [Abstract][Full Text] [Related]
13. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
Meyer-Lindenberg A; Miletich RS; Kohn PD; Esposito G; Carson RE; Quarantelli M; Weinberger DR; Berman KF
Nat Neurosci; 2002 Mar; 5(3):267-71. PubMed ID: 11865311
[TBL] [Abstract][Full Text] [Related]
14. Cortico-limbic-striatal contribution after response and reversal learning: a metabolic mapping study.
Fidalgo C; Conejo NM; González-Pardo H; Arias JL
Brain Res; 2011 Jan; 1368():143-50. PubMed ID: 21036158
[TBL] [Abstract][Full Text] [Related]
15. Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia.
Dean B
Aust N Z J Psychiatry; 2000 Aug; 34(4):560-9. PubMed ID: 10954386
[TBL] [Abstract][Full Text] [Related]
16. The dopamine hypothesis of schizophrenia: a review.
Meltzer HY; Stahl SM
Schizophr Bull; 1976; 2(1):19-76. PubMed ID: 779020
[No Abstract] [Full Text] [Related]
17. Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.
Volk DW
Neurobiol Dis; 2017 Mar; 99():58-65. PubMed ID: 28007586
[TBL] [Abstract][Full Text] [Related]
18. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.
Bertolino A; Knable MB; Saunders RC; Callicott JH; Kolachana B; Mattay VS; Bachevalier J; Frank JA; Egan M; Weinberger DR
Biol Psychiatry; 1999 Mar; 45(6):660-7. PubMed ID: 10187995
[TBL] [Abstract][Full Text] [Related]
19. The neuropathology of schizophrenia. A critical review of the data and their interpretation.
Harrison PJ
Brain; 1999 Apr; 122 ( Pt 4)():593-624. PubMed ID: 10219775
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
Errico F; Napolitano F; Squillace M; Vitucci D; Blasi G; de Bartolomeis A; Bertolino A; D'Aniello A; Usiello A
J Psychiatr Res; 2013 Oct; 47(10):1432-7. PubMed ID: 23835041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
